Science and Ethics at NIH--and FDA

Many of the headlines suggested that the proposed ethics rules for NIH employees have been relaxed. But that's not quite true, as Ted Agres pointed out here. The rules on stock ownership have loosened, yes. But the most important restriction remains. That's the one forbidding those who labor at NIH to do outside consulting for businesses with a stake in NIH's labor.These decisions are a smart move for NIH director Elias A. Zerhouni. The previous proposed stock ownership rules were needl

Written byTabitha M. Powledge
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Many of the headlines suggested that the proposed ethics rules for NIH employees have been relaxed. But that's not quite true, as Ted Agres pointed out here. The rules on stock ownership have loosened, yes. But the most important restriction remains. That's the one forbidding those who labor at NIH to do outside consulting for businesses with a stake in NIH's labor.These decisions are a smart move for NIH director Elias A. Zerhouni. The previous proposed stock ownership rules were needlessly restrictive on most employees. The new stock rules will please them, yet also retain some restrictions on NIH's most senior people. It looks to be a sensible compromise that will reduce opportunities for mischief while making it somewhat less difficult to recruit world-class scientists. But Zerhouni stood firm against the activities that offer the most serious opportunities for corruption of the scientific process: outside consulting for pharmas, biotechs, and related industries. That's the right thing to do, and it's also smart PR. It can't hurt NIH's reputation with the public--or with Congress--that Zerhouni seems serious about trying to keep the agency's science pure.By contrast, on Friday the FDA once again postponed a decision on allowing nonprescription sales of Plan B, the morning-after contraceptive. This is still another craven cave-in to political pressure from the religious right--to say nothing of a repudiation of the scientific committees whose advice the agency is supposed to be taking, which favored wider availability. In these Washington Dog Days, displaying even a little backbone, as Zerhouni did, makes him look like a candidate for canonization.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
December digest cover image of a wooden sculpture comprised of multiple wooden neurons that form a seahorse.
December 2025, Issue 1

Wooden Neurons: An Artistic Vision of the Brain

A neurobiologist, who loves the morphology of cells, turns these shapes into works of art made from wood.

View this Issue
Stacks of cell culture dishes, plates, and flasks with pink cell culture medium on a white background.

Driving Innovation with Cell Culture Essentials

Merck
Stacks of cell culture dishes, plates, and flasks with pink cell culture medium on a white background.

Driving Innovation with Cell Culture Essentials

MilliporeSigma purple logo
Abstract wireframe sphere with colorful dots and connecting lines representing the complex cellular and molecular interactions within the tumor microenvironment.

Exploring the Inflammatory Tumor Microenvironment 

Cellecta logo
An image of a DNA sequencing spectrum with a radial blur filter applied.

A Comprehensive Guide to Next-Generation Sequencing

Integra Logo

Products

brandtech logo

BRANDTECH® Scientific Announces Strategic Partnership with Copia Scientific to Strengthen Sales and Service of the BRAND® Liquid Handling Station (LHS) 

Top Innovations 2026 Contest Image

Enter Our 2026 Top Innovations Contest

Biotium Logo

Biotium Expands Tyramide Signal Amplification Portfolio with Brighter and More Stable Dyes for Enhanced Spatial Imaging

Labvantage Logo

LabVantage Solutions Awarded $22.3 Million U.S Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS